您搜索了: haematopoietic (英语 - 马耳他语)

haematopoietic system
sistema ematopoijetika

haematopoietic growth factors
fatturi ta’ tkabbir ematopoetiku

infectious haematopoietic necrosis (ihn)
nekrożi ematopojetika infettiva (ihn)

epizootic haematopoietic necrosis in fish (ehn),
nekrożi ematopojetika epiżootika fil-ħut (ehn),

glucocerebroside is primarily derived from haematopoietic cell turnover.
12 glukocerebroside hu principalment miksub waqt li jkunu qed isiru ċ- ċelluli ematopoietiċi.

lymphopoietic cancer, haematopoietic cancer, increased leukaemia risk
kanċer limfopojetiku, kanċer ematopojetiku, żieda fir-riskju tal-lewċemja

hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation
ipogammaglobulinemija f’pazjenti wara trapjant ta’ ċelluli staminali ematopoietiċi alloġeneiċi

haematopoietic growth factor has been used in patients with resistant myelosuppression.
il-fattur ta’ tkabbir ematopojetiku ntuża f’pazjenti b’majelosuppressjoni reżistenti.

16 progression of existing haematopoietic malignancies or myelodysplastic syndromes (mds)
progressjoni ta ’ tumuri malinni ematopojetiċi eżistenti jew sindromi mijelodisplastiċi (mds)

the primary toxicities occurred in the gastrointestinal, haematopoietic, and lymphoid systems.
it-tossiċitajiet primarji seħħew fis-sistemi gastrointestinali, ematopojetiċi, u tal-limfojde.

busilvex is administered prior to the haematopoietic progenitor cell transplantation (hpct).
busilvex għandu jittieħed qabel it-trapjant taċ-ċelluli ematopojetiċi proġenitriċi (hpct).

it is given after haploidentical bone marrow transplantation (haematopoietic cell transplantation).
huwa jingħata wara trapjant aploidentiku tal-mudullun (trapjant ta’ ċelluli ematopoetiċi).

the primary toxicities observed in monkeys were associated with the haematopoietic/lymphoreticular systems.
it-tossiċitajiet ewlenin osservati fix-xadini kienu assoċjati ma’ sistemi ematopoietiċi/limforetikulari.

20 out of the 50 (40%) patients in cohort 5 received haematopoietic stem cell transplant.
20 mill-50 (40 %) pazjent f’koorti 5 ingħataw trapjant ta’ ċelloli staminali ematopoetiċi.

some cytotoxic agents exhibit particular toxicities to the haematopoietic progenitor pool and may adversely affect progenitor mobilisation.
xi aġenti ċitotossiċi jesibixxu tossiċita’ partikolari lejn iċ-ċelluli proġenitriċi ematopojetiċi u jistgħu jkollhom effett avvers fuq il-mobilizzazzjoni taċ-ċelluli proġenitriċi.

use of filgrastim, either alone or after chemotherapy, mobilises haematopoietic progenitor cells into peripheral blood.
l-użu ta’ filgrastim, waħdu jew wara kimoterapija, jimmobilizza ċ-celluli proġenitriċi ematopojetiċi għal ġod-demm periferiku.

use of filgrastim, either alone, or after chemotherapy, mobilises haematopoietic progenitor cells into peripheral blood.
l-użu ta’ filgrastim, jew waħdu, jew wara l-kimoterapija, jimmobilizza ċ-ċelluli ematopojetiċi proġenituri fid-demm periferali.